A. Gothwal

Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies

R. Osarogiagbon, J. Unger, M. Overman, 2020, JNCI cancer spectrum.

On the underreporting of health-related quality of life and regulatory approval.

M. Overman, K. Raghav, D. Bhamidipati, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018.

L. Ellis, J. Unger, S. Kopetz, 2019, JAMA oncology.

Underreporting of race/ethnicity in COVID-19 research

M. Overman, A. Dasari, J. Loree, 2021, International Journal of Infectious Diseases.

Sex representation in clinical trials associated with FDA cancer drug approvals differs between solid and hematologic malignancies.

L. Ellis, J. Unger, S. Kopetz, 2020, The oncologist.